Statistical Insights
How statisticians hold the key to more informed develpment decisions.
Respiratory medicine presents a unique set of challenges for clinical researchers and healthcare professionals.
How using synthetic control arms can help overcome development challenges.
How involving patients in defining estimands can improve trial engagement.
How embracing diverse approaches can help teams navigate the challenges of drug development.
Examining the impact for drug developers.
How putting patients at the heart of clinical development will improve it.
How lessons from the past and from failure can provide the foundation to future success.
How did statisticians fare against our simulations in our higher/lower gaming app at the PSI Conference?
Why it’s important to differentiate between power and probability of success.
How statisticians hold the key to more informed develpment decisions.
What Pharma can learn from car manufacturing.
Why simple sample size calculations are just the first step in delivering more agile statistical solutions.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
How the pandemic revealed the need to reassess development approaches.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
How data visualisation supports collaborative decision-making.
Industry insights into the hot topics of estimands, adaptive designs and real-world data.
Why investing in clinical trial design is a more cost-effective and ethical approach.
How estimands help align study objectives with clinical trial design.
How new technologies can update clinical trial approaches.
How early engagement with statisticians can help navigate big data.
How simulation can be used to identify risks for all types of clinical trial designs.
How using simulation to design clinical trials can help with recruitment.
How the pandemic has heightened interest in unlocking the value of RWD.
How engaging with statisticians early in design process builds in more success.
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
How being part of a small company offers agility and creativity.
How the pandemic has been the disruptor that industry needed.
How the life science sector has risen to the challenge of COVID-19.
Statistical Insights
How statisticians hold the key to more informed develpment decisions.
Respiratory medicine presents a unique set of challenges for clinical researchers and healthcare professionals.
How using synthetic control arms can help overcome development challenges.
How involving patients in defining estimands can improve trial engagement.
How embracing diverse approaches can help teams navigate the challenges of drug development.
Examining the impact for drug developers.
How putting patients at the heart of clinical development will improve it.
How lessons from the past and from failure can provide the foundation to future success.
How did statisticians fare against our simulations in our higher/lower gaming app at the PSI Conference?
Why it’s important to differentiate between power and probability of success.
How statisticians hold the key to more informed develpment decisions.
What Pharma can learn from car manufacturing.
Why simple sample size calculations are just the first step in delivering more agile statistical solutions.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
How the pandemic revealed the need to reassess development approaches.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
How data visualisation supports collaborative decision-making.
Industry insights into the hot topics of estimands, adaptive designs and real-world data.
Why investing in clinical trial design is a more cost-effective and ethical approach.
How estimands help align study objectives with clinical trial design.
How new technologies can update clinical trial approaches.
How early engagement with statisticians can help navigate big data.
How simulation can be used to identify risks for all types of clinical trial designs.
How using simulation to design clinical trials can help with recruitment.
How the pandemic has heightened interest in unlocking the value of RWD.
How engaging with statisticians early in design process builds in more success.
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
How being part of a small company offers agility and creativity.
How the pandemic has been the disruptor that industry needed.
How the life science sector has risen to the challenge of COVID-19.
Statistical Insights
How statisticians hold the key to more informed develpment decisions.
Respiratory medicine presents a unique set of challenges for clinical researchers and healthcare professionals.
How using synthetic control arms can help overcome development challenges.
How involving patients in defining estimands can improve trial engagement.
How embracing diverse approaches can help teams navigate the challenges of drug development.
Examining the impact for drug developers.
How putting patients at the heart of clinical development will improve it.
How lessons from the past and from failure can provide the foundation to future success.
How did statisticians fare against our simulations in our higher/lower gaming app at the PSI Conference?
Why it’s important to differentiate between power and probability of success.
How statisticians hold the key to more informed develpment decisions.
What Pharma can learn from car manufacturing.
Why simple sample size calculations are just the first step in delivering more agile statistical solutions.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
How the pandemic revealed the need to reassess development approaches.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
How data visualisation supports collaborative decision-making.
Industry insights into the hot topics of estimands, adaptive designs and real-world data.
Why investing in clinical trial design is a more cost-effective and ethical approach.
How estimands help align study objectives with clinical trial design.
How new technologies can update clinical trial approaches.
How early engagement with statisticians can help navigate big data.
How simulation can be used to identify risks for all types of clinical trial designs.
How using simulation to design clinical trials can help with recruitment.
How the pandemic has heightened interest in unlocking the value of RWD.
How engaging with statisticians early in design process builds in more success.
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
How being part of a small company offers agility and creativity.
How the pandemic has been the disruptor that industry needed.
How the life science sector has risen to the challenge of COVID-19.
Statistical Insights
How statisticians hold the key to more informed develpment decisions.
Respiratory medicine presents a unique set of challenges for clinical researchers and healthcare professionals.
How using synthetic control arms can help overcome development challenges.
How involving patients in defining estimands can improve trial engagement.
How embracing diverse approaches can help teams navigate the challenges of drug development.
Examining the impact for drug developers.
How putting patients at the heart of clinical development will improve it.
How lessons from the past and from failure can provide the foundation to future success.
How did statisticians fare against our simulations in our higher/lower gaming app at the PSI Conference?
Why it’s important to differentiate between power and probability of success.
How statisticians hold the key to more informed develpment decisions.
What Pharma can learn from car manufacturing.
Why simple sample size calculations are just the first step in delivering more agile statistical solutions.
What is needed to move the dial on the use of innovative trial designs?
How building models opened up new possibilities.
Why more data does not always mean useful data.
How novel approaches to clinical trial design and analysis supports delivery of treatments for rare diseases.
How the pandemic revealed the need to reassess development approaches.
How synthetic control arms can add another dimension to clinical trials.
How a better understanding of mutual relationships improves clinical trial design.
How data visualisation supports collaborative decision-making.
Industry insights into the hot topics of estimands, adaptive designs and real-world data.
Why investing in clinical trial design is a more cost-effective and ethical approach.
How estimands help align study objectives with clinical trial design.
How new technologies can update clinical trial approaches.
How early engagement with statisticians can help navigate big data.
How simulation can be used to identify risks for all types of clinical trial designs.
How using simulation to design clinical trials can help with recruitment.
How the pandemic has heightened interest in unlocking the value of RWD.
How engaging with statisticians early in design process builds in more success.
How synthetic data offers a solution to unleashing powerful insights from real-world data.
How unlocking data insights from the real world will help us to see the bigger picture.
Why Belfast is a great place to set up a life science business.
How being part of a small company offers agility and creativity.
How the pandemic has been the disruptor that industry needed.
How the life science sector has risen to the challenge of COVID-19.
Want to find out more? Get in touch.